Rob Ryan
Fortuna: 5 M $ al 31/05/2026
Fortuna: 5 M $ al 31/05/2026
Rob Ryan currently works at ASP Isotopes, Inc., as Independent Non-Executive Director from 2024.
Mr. Ryan also formerly worked at Balbec Capital LP, as Partner from 2019 to 2023.
Mr. Ryan received his graduate degree from the University of Leicester.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ASP ISOTOPES, INC. 0,52 % | 29/04/2026 | 652.222 ( 0,52 % ) | 5 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ASP ISOTOPES INC. | Director/Miembro de la Junta | 14/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Balbec Capital LP
Balbec Capital LP Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 01/07/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Leicester
University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Balbec Capital LP
Balbec Capital LP Investment ManagersFinance Acts as an alternative investment manager | Finance |
ASP Isotopes, Inc.
ASP Isotopes, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.